U.S. Retail Distributors Stock News

In recent months, PepsiCo has begun a major reshaping of its portfolio and strategy, including cutting about one-fifth of its snacks and beverages from 2026, quietly discontinuing some niche flavors, and integrating acquisitions such as Siete and Poppi while expanding distribution partnerships like Alani Nu. At the same time, activist investor Elliott Investment Management has taken a multi-billion-dollar stake and, alongside PepsiCo’s refreshed sustainability and marketing focus, is pushing...

comScore, Inc. ( NASDAQ:SCOR ) shareholders would be excited to see that the share price has had a great month, posting...

The Morning Bull - US Market Morning Update Thursday, Jan, 22 2026 US stock futures are pointing higher this morning, with key benchmarks like the E-mini S&P 500 and Nasdaq-100 futures up around 0.5% to 0.8%, as investors weigh cooling inflation signals against fresh signs of housing strain. The US PCE price gauge, a key Fed inflation yardstick, is seen rising 0.2% in November, with annual inflation projected at 2.8%, which suggests the cost of living is still rising but not at an aggressive...

If you are wondering whether Gartner's current share price still reflects the quality of the business, you are not alone. A closer look at its valuation can help frame that question more clearly. The stock last closed at US$232.44, with returns of a 2.7% decline over 7 days, 7.2% decline over 30 days, 1.9% decline year to date, 55.7% decline over 1 year and 29.3% decline over 3 years, while the 5 year return sits at 53.3%. Recent coverage of Gartner has focused on its role as a key research...

Tyra Biosciences recently strengthened its leadership team by appointing Bhavesh Ashar as Chief Operating Officer and Heather Faulds as Chief Regulatory Officer, reinforcing its focus on developing precision medicines. These appointments, alongside growing attention on upcoming Phase 2 study readouts, have reinforced investor interest in how the company is positioning itself for its next phase of development. We’ll now examine how the expanded leadership bench, especially the new regulatory...

Options activity and price slide put Figma (FIG) in the spotlight Unusual options trading around Figma (FIG), combined with a recent share price drop and mixed analyst ratings, has pushed the design software company onto many investors radar this week. See our latest analysis for Figma. The recent options activity comes during a sharp reset in sentiment. The share price is at $27.07 after a 16.35% decline over 7 days and a 49.26% decline over 90 days, indicating that momentum has been fading...

Recent performance snapshot for D.R. Horton D.R. Horton (DHI) has drawn investor interest after recent trading, with the stock last closing at $158.11. That price is associated with a one-month return of 8.76% and a past three-month return that has been nearly flat. See our latest analysis for D.R. Horton. After a recent 1-day share price return of 3.21%, D.R. Horton’s 30-day share price return of 8.76% and year to date share price return of 8.50% point to building momentum, while the 5-year...

Long term investing is the way to go, but that doesn't mean you should hold every stock forever. We don't wish...

XP (NasdaqGS:XP) drew fresh attention after Jefferies began coverage with a positive rating, alongside third quarter results that topped analyst expectations and new plans for a cash dividend and share repurchase program. See our latest analysis for XP. The latest moves fit into a strong recent run, with a 30 day share price return of 17.95% and an 18.17% year to date gain, while the 1 year total shareholder return of 59.87% contrasts with a negative 51.82% total shareholder return over five...

The Diana Shipping Inc. ( NYSE:DSX ) share price has done very well over the last month, posting an excellent gain of...

Stoke Therapeutics (STOK) recently outlined faster enrollment and a clearer data timeline for its Phase 3 EMPEROR study of zorevunersen in Dravet syndrome, along with ongoing FDA discussions on potential expedited review options. See our latest analysis for Stoke Therapeutics. The latest Dravet syndrome update comes after a mixed period for the shares, with a 1 day share price return of 2.72% contrasting with a 30 day share price return decline of 11.99%. The 1 year total shareholder return...

CrowdStrike recently advanced its Global Data Sovereignty initiative by planning new in-country cloud deployments in Saudi Arabia, India, and the United Arab Emirates, allowing customers to keep security data within national borders while using the Falcon platform. This move highlights how CrowdStrike is tailoring its cloud infrastructure to jurisdictions with strict data residency rules without fragmenting its global threat intelligence model. We’ll now examine how expanding regional...

Sify Technologies (NasdaqCM:SIFY) is pursuing an IPO for its data center subsidiary to fund expansion and refinance debt. The IPO plan is linked to strong demand in AI focused data center capacity. The company is preparing to inaugurate a new data centre facility in Karnataka as part of its digital infrastructure build out. Sify Technologies, trading at $14.63, has recorded a 1 year share price return of 350.2%, alongside a 23.0% return over the past 30 days and 19.1% year to date. These...

Polaris Inc. recently reported quarterly results showing revenue and earnings ahead of analyst expectations, even as long-serving director Kevin M. Farr announced his resignation as Audit Committee Chair effective January 14, 2026. At the same time, Polaris paired this operational momentum, including continued motorsport success at the 2026 Dakar Rally, with full-year guidance that was more cautious than that of its leisure-products peers. Next, we’ll examine how Polaris’ strong quarter but...

Medtronic (NYSE:MDT) has entered into a partnership with Precision Neuroscience to advance brain computer interface technology in neurosurgery. The company has also agreed to acquire a significant stake in Anteris Technologies, a developer of a transcatheter aortic valve replacement device. For a medical technology giant like Medtronic, these moves touch two core areas: neurosurgery and structural heart care. Brain computer interface tools aim to bring new options into the operating room,...

Herbalife Ltd. ( NYSE:HLF ) shares have continued their recent momentum with a 27% gain in the last month alone. The...

Why Hormel Foods is back on investors’ radar Hormel Foods (HRL) has drawn fresh attention after a period of mixed share performance, with a 1-day decline and flat past week offset by modest gains over the past month and past 3 months. See our latest analysis for Hormel Foods. At a share price of $24.43, Hormel Foods has seen modest recent momentum, with a positive year to date share price return but a weaker 1 year total shareholder return indicating that longer term holders have experienced...

Most readers would already be aware that Academy Sports and Outdoors' (NASDAQ:ASO) stock increased significantly by 19...

XPO (NYSE:XPO) has been recognized by Fortune as one of the World's Most Admired Companies for 2026. The company is the only pure play North American less than truckload transportation provider included in the 2026 list. The recognition highlights XPO's standing in the global transportation sector and reflects the role of its leadership and workforce. XPO enters 2026 with Fortune's World's Most Admired Companies recognition and a share price of $149.82, putting a fresh spotlight on its...

If you are wondering whether Johnson & Johnson shares still offer value at around US$218.01, you are not alone. Many investors are asking the same question as the stock sits near its recent levels. The stock has been relatively steady over the last week with a 0.2% decline, while the 30 day return of 5.2% and 1 year return of 54.7% put recent performance in clear focus. Recent headlines around Johnson & Johnson continue to focus on its position as a large healthcare company, including...

TG Therapeutics recently reported preliminary results indicating BRIUMVI U.S. net product revenue of about US$182 million for the fourth quarter of 2025 and approximately US$594 million for the full year, contributing to an estimated US$616 million in total global 2025 revenue. The company also issued 2026 guidance targeting about US$875–900 million in global revenue, with BRIUMVI U.S. net product revenue expected to account for roughly US$825–850 million, underscoring how central this...

It's not a stretch to say that Privia Health Group, Inc.'s ( NASDAQ:PRVA ) price-to-sales (or "P/S") ratio of 1.4x...

Why Newegg Commerce (NEGG) Is On Investors’ Radar Today Newegg Commerce (NEGG) has caught attention after recent share price moves, with the stock showing a 17.7% decline over the past day and double digit declines over the past week and month. For investors tracking short term swings, these moves sit against a one year total return figure of 4.42%. This highlights how quickly sentiment around the electronics focused e retailer can shift. See our latest analysis for Newegg Commerce. The...

To avoid investing in a business that's in decline, there's a few financial metrics that can provide early indications...